|
|
|
David Pernock
Chairman and Chief Executive Officer
Declan Daly
Chief Operating Officer and Chief Financial Officer
John Maslowski
Vice President, Operations
David Pernock
Chairman and Chief Executive Officer
David Pernock, Chairman of the Board and CEO, joined Fibrocell Science with extensive leadership experience in healthcare sales and commercialization, building business units, partnerships, and brands, most recently as senior vice president, Pharmaceuticals, Vaccines (Biologics), Oncology, Acute Care and HIV at GlaxoSmithKline. Over a long career at GlaxoSmithKline,
Mr. Pernock was promoted numerous times to levels of increasing responsibility including vice president of Marketing, Pharmaceuticals; vice president of Sales and Marketing, Oncology; vice president of Managed Care; and, vice president of Sales. Mr. Pernock holds a BS in Business Administration from Arizona State University. He serves on many philanthropic organizations.
Declan Daly
Chief Operating Officer
and Chief Financial Officer
Declan Daly was named Chief Operating Officer
and Chief Financial Officer of Fibrocell Science, Inc. in September 2009. Prior to the reorganization of Isolagen, Inc. as Fibrocell, he had served as Chief Executive Officer of Isolagen. He originally joined Isolagen as Chief Financial Officer (CFO) and Executive Vice President
- Europe in June 2006, and was promoted to Chief Operating Officer and CFO in June 2007. Prior to joining Isolagen, Mr. Daly spent more than seven years with Inamed Corporation and most recently served as CFO. Prior to becoming CFO, Mr. Daly served as Inamed's Senior Vice President, Corporate Controller and Principal Accounting Officer, and previously as Vice President of Finance & Administration of Inamed International Corp. based in Europe. Mr. Daly holds a BA in Management Science and Industrial Systems Studies from Trinity College in Dublin and is a Fellow of the Institute of Chartered Accountants in Ireland.
John Maslowski
Vice President, Operations
Mr. Maslowski joined predecessor company Isolagen in 2005 and has since held various management positions in Manufacturing and Quality Assurance with the Company. Prior to Isolagen, Mr. Maslowski was employed at Wyeth Pharmaceuticals from 2001 to 2005, serving most recently as Quality Assurance Investigations Manager in support of manufacturing. Previously, Mr. Maslowski held positions with Merck Research Laboratories and Teva Pharmaceuticals. Mr. Maslowski holds a BS in Biology from Ursinus College and MS in Biology from Villanova University. In addition, he is a Certified Quality Auditor through the American Society for Quality.
|
|
